Creative Medical Technology (CELZ) Short Interest Ratio & Short Volume

Short interest is the volume of Creative Medical Technology shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 36,100 shares of CELZ short. 1.46% of Creative Medical Technology's shares are currently sold short. Learn More on Creative Medical Technology's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.46% of Creative Medical Technology's floating shares are currently sold short.

Creative Medical Technology saw a decline in short interest in March. As of March 15th, there was short interest totaling 36,100 shares, a decline of 80.5% from the previous total of 184,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Creative Medical Technology currently has issued a total of 1,748,000 shares. Some of Creative Medical Technology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Creative Medical Technology currently has a public float of 2,480,000 shares.

1.46% of Creative Medical Technology's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Creative Medical Technology: 23andMe Holding Co. (11.90%), Senti Biosciences, Inc. (0.35%), Chemomab Therapeutics Ltd. (1.63%), GlycoMimetics, Inc. (4.38%), Elevation Oncology, Inc. (16.81%), Carisma Therapeutics, Inc. (2.04%), NextCure, Inc. (0.30%), MEI Pharma, Inc. (0.05%), Cocrystal Pharma, Inc. (0.02%), Sol-Gel Technologies Ltd. (0.12%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks.

Short selling CELZ is an investing strategy that aims to generate trading profit from Creative Medical Technology as its price is falling. CELZ shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Creative Medical Technology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CELZ, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CELZ, twice per month. The most recent reporting period available is March, 15 2025.